212 related articles for article (PubMed ID: 26206626)
1. Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries.
Hunter CA; Kirson NY; Desai U; Cummings AK; Faries DE; Birnbaum HG
Alzheimers Dement; 2015 Aug; 11(8):887-95. PubMed ID: 26206626
[TBL] [Abstract][Full Text] [Related]
2. Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.
Happich M; Kirson NY; Desai U; King S; Birnbaum HG; Reed C; Belger M; Lenox-Smith A; Price D
J Alzheimers Dis; 2016 May; 53(1):171-83. PubMed ID: 27163798
[TBL] [Abstract][Full Text] [Related]
3. Assessing the economic burden of Alzheimer's disease patients first diagnosed by specialists.
Kirson NY; Desai U; Ristovska L; Cummings AK; Birnbaum HG; Ye W; Andrews JS; Ball D; Kahle-Wrobleski K
BMC Geriatr; 2016 Jul; 16():138. PubMed ID: 27400711
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer's dementia in a population setting.
Sicras A; Rejas J; Arco S; Flores E; Ortega G; Esparcia A; Suárez A; Gordillo MJ
Dement Geriatr Cogn Disord; 2005; 19(5-6):305-15. PubMed ID: 15785031
[TBL] [Abstract][Full Text] [Related]
5. Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's disease.
Kaltenboeck A; Johnson SJ; Davis MR; Birnbaum HG; Carroll CA; Tarrants ML; Siderowf AD
Parkinsonism Relat Disord; 2012 May; 18(4):321-6. PubMed ID: 22177623
[TBL] [Abstract][Full Text] [Related]
6. Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population.
Geldmacher DS; Kirson NY; Birnbaum HG; Eapen S; Kantor E; Cummings AK; Joish VN
Appl Health Econ Health Policy; 2013 Aug; 11(4):407-13. PubMed ID: 23700254
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Pathways to Alzheimer Disease: Costs Incurred in a Medicare Population.
Gilden DM; Kubisiak JM; Sarsour K; Hunter CA
Alzheimer Dis Assoc Disord; 2015; 29(4):330-7. PubMed ID: 25635340
[TBL] [Abstract][Full Text] [Related]
8. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
Lu S; Hill J; Fillit H
Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
[TBL] [Abstract][Full Text] [Related]
9. Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's.
Zhao Y; Kuo TC; Weir S; Kramer MS; Ash AS
BMC Health Serv Res; 2008 May; 8():108. PubMed ID: 18498638
[TBL] [Abstract][Full Text] [Related]
10. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
Fillit H; Hill JW; Futterman R
Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
[TBL] [Abstract][Full Text] [Related]
11. The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.
Suehs BT; Davis CD; Alvir J; van Amerongen D; Pharmd NC; Joshi AV; Faison WE; Shah SN
Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):384-92. PubMed ID: 23687180
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare.
Hill JW; Futterman R; Duttagupta S; Mastey V; Lloyd JR; Fillit H
Neurology; 2002 Jan; 58(1):62-70. PubMed ID: 11781407
[TBL] [Abstract][Full Text] [Related]
13. The direct health care cost to Medicare of Down syndrome dementia as compared with Alzheimer's disease among 2015 Californian beneficiaries.
Bayen E; Yaffe K; Cleret de Langavant L; Chen Y; Possin KL
Ann Phys Rehabil Med; 2021 Jan; 64(1):101430. PubMed ID: 32853759
[TBL] [Abstract][Full Text] [Related]
14. Implications of early treatment among Medicaid patients with Alzheimer's disease.
Geldmacher DS; Kirson NY; Birnbaum HG; Eapen S; Kantor E; Cummings AK; Joish VN
Alzheimers Dement; 2014 Mar; 10(2):214-24. PubMed ID: 23643457
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
Allan LM; Ballard CG; Burn DJ; Kenny RA
J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
[TBL] [Abstract][Full Text] [Related]
16. Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer's disease in an administrative claims database.
Nair R; Haynes VS; Siadaty M; Patel NC; Fleisher AS; Van Amerongen D; Witte MM; Downing AM; Fernandez LAH; Saundankar V; Ball DE
BMC Geriatr; 2018 Oct; 18(1):243. PubMed ID: 30326851
[TBL] [Abstract][Full Text] [Related]
17. Gender Differences: A Lifetime Analysis of the Economic Burden of Alzheimer's Disease.
Yang Z; Levey A
Womens Health Issues; 2015; 25(5):436-40. PubMed ID: 26363924
[TBL] [Abstract][Full Text] [Related]
18. 2011 Alzheimer's disease facts and figures.
Alzheimer's Association
Alzheimers Dement; 2011 Mar; 7(2):208-44. PubMed ID: 21414557
[TBL] [Abstract][Full Text] [Related]
19. Implications of comorbidity on costs for patients with Alzheimer disease.
Kuo TC; Zhao Y; Weir S; Kramer MS; Ash AS
Med Care; 2008 Aug; 46(8):839-46. PubMed ID: 18665064
[TBL] [Abstract][Full Text] [Related]
20. The costs of vascular dementia: a comparison with Alzheimer's disease.
Fillit H; Hill J
J Neurol Sci; 2002 Nov; 203-204():35-9. PubMed ID: 12417354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
